These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 30543413)
1. Cysteine-Directed Bioconjugation of a Platinum(II)-Acridine Anticancer Agent. Yao X; Tracy CM; Bierbach U Inorg Chem; 2019 Jan; 58(1):43-46. PubMed ID: 30543413 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a Platinum-Acridine Anticancer Agent and Its Liposomal Formulation in an in vivo Model of Lung Adenocarcinoma. Ding S; Hackett CL; Liu F; Hackett RG; Bierbach U ChemMedChem; 2021 Jan; 16(2):412-419. PubMed ID: 32975041 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore. Martins ET; Baruah H; Kramarczyk J; Saluta G; Day CS; Kucera GL; Bierbach U J Med Chem; 2001 Dec; 44(25):4492-6. PubMed ID: 11728195 [TBL] [Abstract][Full Text] [Related]
4. PT-ACRAMTU, a platinum-acridine anticancer agent, lengthens and aggregates, but does not stiffen or soften DNA. Dutta S; Snyder MJ; Rosile D; Binz KL; Roll EH; Suryadi J; Bierbach U; Guthold M Cell Biochem Biophys; 2013; 67(3):1103-13. PubMed ID: 23636685 [TBL] [Abstract][Full Text] [Related]
5. Comparative chemogenomics to examine the mechanism of action of dna-targeted platinum-acridine anticancer agents. Cheung-Ong K; Song KT; Ma Z; Shabtai D; Lee AY; Gallo D; Heisler LE; Brown GW; Bierbach U; Giaever G; Nislow C ACS Chem Biol; 2012 Nov; 7(11):1892-901. PubMed ID: 22928710 [TBL] [Abstract][Full Text] [Related]
6. Redesigning the DNA-targeted chromophore in platinum-acridine anticancer agents: a structure-activity relationship study. Pickard AJ; Liu F; Bartenstein TF; Haines LG; Levine KE; Kucera GL; Bierbach U Chemistry; 2014 Dec; 20(49):16174-87. PubMed ID: 25302716 [TBL] [Abstract][Full Text] [Related]
7. Large-Pore Functionalized Mesoporous Silica Nanoparticles as Drug Delivery Vector for a Highly Cytotoxic Hybrid Platinum-Acridine Anticancer Agent. Zheng Y; Fahrenholtz CD; Hackett CL; Ding S; Day CS; Dhall R; Marrs GS; Gross MD; Singh R; Bierbach U Chemistry; 2017 Mar; 23(14):3386-3397. PubMed ID: 28122141 [TBL] [Abstract][Full Text] [Related]
8. Bis(acridinylthiourea)platinum(II) complexes: synthesis, DNA affinity, and biological activity in glioblastoma cells. Augustus TM; Anderson J; Hess SM; Bierbach U Bioorg Med Chem Lett; 2003 Mar; 13(5):855-8. PubMed ID: 12617907 [TBL] [Abstract][Full Text] [Related]
9. A membrane transporter determines the spectrum of activity of a potent platinum-acridine hybrid anticancer agent. Yao X; Watkins NH; Brown-Harding H; Bierbach U Sci Rep; 2020 Sep; 10(1):15201. PubMed ID: 32939009 [TBL] [Abstract][Full Text] [Related]
10. Development of Prodrug-Payloads for Targeted Therapeutic Applications of Platinum-Acridine Anticancer Agents. Mancera-Ortiz IY; Chen J; Slade TA; Yao X; Zhang S; Day CS; Bierbach U Bioconjug Chem; 2023 Oct; 34(10):1873-1881. PubMed ID: 37813818 [TBL] [Abstract][Full Text] [Related]
11. Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer. Gou Y; Zhang Y; Qi J; Chen S; Zhou Z; Wu X; Liang H; Yang F Oncotarget; 2016 Oct; 7(41):67004-67019. PubMed ID: 27564255 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, cytotoxicity and structure-activity relationships between ester and amide functionalities in novel acridine-based platinum(II) complexes. Bouyer F; Moretto J; Pertuit D; Szollosi A; Lacaille-Dubois MA; Blache Y; Chauffert B; Desbois N J Inorg Biochem; 2012 May; 110():51-7. PubMed ID: 22459174 [TBL] [Abstract][Full Text] [Related]
13. Using a build-and-click approach for producing structural and functional diversity in DNA-targeted hybrid anticancer agents. Ding S; Qiao X; Kucera GL; Bierbach U J Med Chem; 2012 Nov; 55(22):10198-203. PubMed ID: 23074987 [TBL] [Abstract][Full Text] [Related]
14. A non-cross-linking platinum-acridine agent with potent activity in non-small-cell lung cancer. Ma Z; Choudhury JR; Wright MW; Day CS; Saluta G; Kucera GL; Bierbach U J Med Chem; 2008 Dec; 51(23):7574-80. PubMed ID: 19012390 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological activity, and DNA-damage profile of platinum-threading intercalator conjugates designed to target adenine. Guddneppanavar R; Saluta G; Kucera GL; Bierbach U J Med Chem; 2006 Jun; 49(11):3204-14. PubMed ID: 16722638 [TBL] [Abstract][Full Text] [Related]
16. DNA-directed alkylating agents. 5. Acridinecarboxamide derivatives of (1,2-diaminoethane)dichloroplatinum(II). Lee HH; Palmer BD; Baguley BC; Chin M; McFadyen WD; Wickham G; Thorsbourne-Palmer D; Wakelin LP; Denny WA J Med Chem; 1992 Aug; 35(16):2983-7. PubMed ID: 1501223 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of non-cisplatin type DNA-targeted platinum anticancer agents: DNA interactions of novel acridinylthioureas and their platinum conjugates. Baruah H; Rector CL; Monnier SM; Bierbach U Biochem Pharmacol; 2002 Jul; 64(2):191-200. PubMed ID: 12123739 [TBL] [Abstract][Full Text] [Related]
18. A Nanobody-Conjugated DNA Nanoplatform for Targeted Platinum-Drug Delivery. Wu T; Liu J; Liu M; Liu S; Zhao S; Tian R; Wei D; Liu Y; Zhao Y; Xiao H; Ding B Angew Chem Int Ed Engl; 2019 Oct; 58(40):14224-14228. PubMed ID: 31389144 [TBL] [Abstract][Full Text] [Related]
19. A platinum Chugaev carbene complex as a potent anticancer agent. Alves G; Morel L; El-Ghozzi M; Avignant D; Legeret B; Nauton L; Cisnetti F; Gautier A Chem Commun (Camb); 2011 Jul; 47(27):7830-2. PubMed ID: 21647511 [TBL] [Abstract][Full Text] [Related]
20. Palladium(ii) and platinum(ii) saccharinate complexes with bis(diphenylphosphino)methane/ethane: synthesis, S-phase arrest and ROS-mediated apoptosis in human colon cancer cells. Icsel C; Yilmaz VT; Aygun M; Cevatemre B; Alper P; Ulukaya E Dalton Trans; 2018 Aug; 47(33):11397-11410. PubMed ID: 30062356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]